跳至主要内容
临床试验/CTRI/2024/10/075601
CTRI/2024/10/075601尚未招募2/3 期

A Randomized controlled clinical trial to study the efficacy of PIPPALIYUKT DASHMOOL KWATH with RASONADI KWATH in the management of Amavata.

Tilak Ayurved Mahavidyalaya1 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2024年11月10日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
入组人数
78
试验地点
1
主要终点
Decrease in symptoms like Sandhishool, Sandhistabdhata, Sparshaasahatva, Sandhishoth, Aruchi, Angagaurav, Daha, Agnimandya, Angamarda

研究概览

简要总结

In this study Pippaliyukta Dashmool Kwath and Rasonadi Kwath will be given to the group A & B respectively.Efficacy will be assessed on the basis of objective criterias for statistical analysis. Gradations will be designed according to symptoms and each symptom will be scoredbefore and after treatment and on every weekly follow up.The effect of treatment result will be assessed in regards to clinical signs and symptoms on the basis of grading and scoring system.The signs and symptoms will be asesed by adapting the suitable scoring system.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patient who have classical symptoms of Aamvata like Sandhishool, Sandhishotha, Sparshasahatva, Sandhinigrah, Agnimandya, Aruchi, Daha, Alasya, Jwar, Trishna, Gaurav.
  • 2.Patients who are not on any conventional medicine such as Methotrexate, Cloroquine, Glucocorticoids in the last one month prior to period.
  • 3.Patient willing to give informed consent.

排除标准

  • Traumatic Arthritis, Psoriatic Arthritis, Gouty Arthritis, Septic Arthritis, Pots disease.
  • 2.Comorbid conditions such as past history of Cardiac Arrythmia, Acute coronary Syndrome, Diabetes, Hypertension, MI, Stroke, Renal dysfunction in last 3 months.
  • 3.Patient taking participation in any other clinical trial in last 3 months.
  • 5.Patient not willing for clinical trial.

结局指标

主要结局

Decrease in symptoms like Sandhishool, Sandhistabdhata, Sparshaasahatva, Sandhishoth, Aruchi, Angagaurav, Daha, Agnimandya, Angamarda

时间窗: 15 days

次要结局

  • Decrease in symptoms like Sandhishool, Sandhistabdhata, Sparshaasahatva, Sandhishoth, Aruchi, Angagaurav, Daha, Agnimandya, Angamarda(6 Months)

研究者

申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Vd. Bhagyashri Pralhad Patil

Tilak Ayurved Mahavidyalaya

研究点 (1)

Loading locations...

相似试验